{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:28:32Z","timestamp":1792801712975,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["1R01AI161175"],"award-info":[{"award-number":["1R01AI161175"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012403","name":"Texas Biomedical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012403","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011104","name":"Universitat Aut\u00f2noma de Barcelona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011104","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["S10OD024978"],"award-info":[{"award-number":["S10OD024978"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.isci.2026.117166","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T09:33:31Z","timestamp":1786440811000},"page":"117166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Emergence of neutralizing RBD antibodies following Omicron infection with limited activity against ancestral SARS-CoV-2"],"prefix":"10.1016","volume":"29","author":[{"given":"Michael S.","family":"Piepenbrink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simran","family":"Panjwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra R.","family":"Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison M.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Kizziah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara H.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory C.","family":"Ippolito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan B.","family":"Erdmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Goepfert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Martinez-Sobrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Kobie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2163-5550","authenticated-orcid":false,"given":"Mark R.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.117166_bib2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cmi.2025.09.012","article-title":"The effect of remdesivir and nirmatrelvir\/ritonavir on mortality in patients hospitalized with COVID-19 during the Omicron era: an emulated target trial","volume":"32","author":"Valik","year":"2026","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.isci.2026.117166_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/irv.70065","article-title":"Comparative Effectiveness of Antivirals and Monoclonal Antibodies for Treating COVID-19 Patients Infected With Omicron Variant: A Systematic Review and Network Meta-Analysis","volume":"18","author":"Lau","year":"2024","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.isci.2026.117166_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106294","article-title":"Pooled analysis of the MANTICO2 and MONET randomized controlled trials comparing drug efficacy for early treatment of COVID-19 during Omicron waves","volume":"89","author":"Mazzotta","year":"2024","journal-title":"J. Infect."},{"key":"10.1016\/j.isci.2026.117166_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/idr17030043","article-title":"Incidence of COVID-19 Symptom Rebound After Treatment with Remdesivir","volume":"17","author":"Gupta","year":"2025","journal-title":"Infect. Dis. Rep."},{"key":"10.1016\/j.isci.2026.117166_bib6","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","article-title":"Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology","volume":"183","author":"Piccoli","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.117166_bib7","first-page":"131","article-title":"Monoclonal Antibody Therapies Against SARS-CoV-2: Promises and Realities","volume":"443","author":"Focosi","year":"2025","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.isci.2026.117166_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41579-025-01255-x","article-title":"SARS-CoV-2 variants: biology, pathogenicity, immunity and control","volume":"24","author":"Uraki","year":"2026","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.isci.2026.117166_bib10","unstructured":"WHO. One year since the emergence of COVID-19 virus variant Omicron. https:\/\/www.who.int\/news-room\/feature-stories\/detail\/one-year-since-the-emergence-of-omicron."},{"key":"10.1016\/j.isci.2026.117166_bib11","article-title":"Evaluation of the evolution of SARS-CoV-2 Omicron variant and the spreading of LP.8.1 and NB.1.8.1","author":"Yi","year":"2025","journal-title":"medRxiv"},{"key":"10.1016\/j.isci.2026.117166_bib12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s44197-025-00510-x","article-title":"The Emergence and Characterization of SARS-CoV-2 Variant XFG (\u201cStratus\u201d): Comparative Virological, Epidemiological, and Public-Health Perspectives","volume":"16","author":"Azhar","year":"2026","journal-title":"J. Epidemiol. Glob. Health"},{"key":"10.1016\/j.isci.2026.117166_bib13","article-title":"Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination","volume":"5","author":"Voss","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.isci.2026.117166_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s44298-024-00063-z","article-title":"Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variants","volume":"2","author":"Piepenbrink","year":"2024","journal-title":"Npj Viruses"},{"key":"10.1016\/j.isci.2026.117166_bib15","doi-asserted-by":"crossref","first-page":"7196","DOI":"10.1016\/j.cell.2024.09.026","article-title":"A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversification","volume":"187","author":"Rosen","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.117166_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012650","article-title":"Delineating the functional activity of antibodies with cross-reactivity to SARS-CoV-2, SARS-CoV-1 and related sarbecoviruses","volume":"20","author":"Ruiz","year":"2024","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2026.117166_bib17","article-title":"Structural and functional analysis of VYD222: a broadly neutralizing antibody against SARS-CoV-2 variants","author":"Yuan","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.isci.2026.117166_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.20411\/pai.v10i1.752","article-title":"Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP3.3 From Approved Monoclonal Antibodies","volume":"10","author":"Planas","year":"2024","journal-title":"Pathog. Immun."},{"key":"10.1016\/j.isci.2026.117166_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116440","article-title":"Antibody evasion and receptor binding of SARS-CoV-2 LP.8.1.1, NB.1.8.1, XFG, and related subvariants","volume":"44","author":"Mellis","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2026.117166_bib20","article-title":"Antibody evasiveness of SARS-CoV-2 subvariants KP.3.1.1 and XEC","volume":"44","author":"Wang","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2026.117166_bib21","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.abd0827","article-title":"Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail","volume":"369","author":"Hansen","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.117166_bib22","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","article-title":"BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection","volume":"608","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.117166_bib23","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.abb7269","article-title":"A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV","volume":"368","author":"Yuan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.117166_bib24","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2205784119","article-title":"A broad and potent neutralization epitope in SARS-related coronaviruses","volume":"119","author":"Yuan","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.117166_bib25","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41586-020-2852-1","article-title":"SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies","volume":"588","author":"Barnes","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.117166_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41586-021-03817-4","article-title":"Broad sarbecovirus neutralization by a human monoclonal antibody","volume":"597","author":"Tortorici","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.117166_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj7125","article-title":"A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice","volume":"14","author":"Martinez","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2026.117166_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111845","article-title":"Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents","volume":"41","author":"Cao","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2026.117166_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010691","article-title":"Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody","volume":"18","author":"Piepenbrink","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.isci.2026.117166_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00006-26","article-title":"A cocktail of SARS-CoV-2 S stem helix domain and receptor binding domain human monoclonal antibodies prevents the emergence of viral escape mutants","volume":"14","author":"Ma","year":"2026","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.isci.2026.117166_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104126","article-title":"An overview of the development of pharmacotherapeutics targeting SARS-CoV-2","volume":"29","author":"Lucaj","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.isci.2026.117166_bib32","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.1093\/cid\/ciac601","article-title":"Sotrovimab Resistance and Viral Persistence After Treatment of Immunocompromised Patients Infected With the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant","volume":"76","author":"Huygens","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.isci.2026.117166_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.691715","article-title":"Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern","volume":"12","author":"Deshpande","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.117166_bib34","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1126\/science.abc7424","article-title":"Broad neutralization of SARS-related viruses by human monoclonal antibodies","volume":"369","author":"Wec","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.117166_bib35","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/S1473-3099(25)00658-9","article-title":"Epidemiological and virological update on the emerging SARS-CoV-2 variant BA.3.2","volume":"26","author":"Zhang","year":"2026","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2026.117166_bib36","doi-asserted-by":"crossref","first-page":"130","DOI":"10.15585\/mmwr.mm7510a1","article-title":"Early Detection and Surveillance of the SARS-CoV-2 Variant BA.3.2 \u2014 Worldwide, November 2024\u2013February 2026","volume":"75","author":"Shakya","year":"2026","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.isci.2026.117166_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115941","article-title":"Structural and functional insights into the evolution of SARS-CoV-2 KP.3.1.1 spike protein","volume":"44","author":"Feng","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2026.117166_bib38","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2220948120","article-title":"Identification of broad, potent antibodies to functionally constrained regions of SARS-CoV-2 spike following a breakthrough infection","volume":"120","author":"Guenthoer","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.117166_bib39","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jsb.2010.03.007","article-title":"Quantitative analysis of cryo-EM density map segmentation by watershed and scale-space filtering, and fitting of structures by alignment to regions","volume":"170","author":"Pintilie","year":"2010","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.isci.2026.117166_bib40","article-title":"Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters","volume":"2","author":"Piepenbrink","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.isci.2026.117166_bib41","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1038\/s41598-018-22307-8","article-title":"A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody","volume":"8","author":"Nogales","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.117166_bib42","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jviromet.2009.02.014","article-title":"High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies","volume":"158","author":"Liao","year":"2009","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.isci.2026.117166_bib43","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","article-title":"Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning","volume":"329","author":"Tiller","year":"2008","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.isci.2026.117166_bib44","article-title":"Persistence of HIV-1 Env-Specific Plasmablast Lineages in Plasma Cells after Vaccination in Humans","volume":"1","author":"Basu","year":"2020","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.isci.2026.117166_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2020.113995","article-title":"Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2","volume":"287","author":"Park","year":"2021","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.isci.2026.117166_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/v12050513","article-title":"Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays","volume":"12","author":"Crawford","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2026.117166_bib47","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","article-title":"cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination","volume":"14","author":"Punjani","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.isci.2026.117166_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4792","article-title":"UCSF ChimeraX: Tools for structure building and analysis","volume":"32","author":"Meng","year":"2023","journal-title":"Protein Sci."},{"key":"10.1016\/j.isci.2026.117166_bib49","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.isci.2026.117166_bib50","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1107\/S2059798318002425","article-title":"ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps","volume":"74","author":"Croll","year":"2018","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.isci.2026.117166_bib51","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1107\/S2059798318006551","article-title":"Real-space refinement in PHENIX for cryo-EM and crystallography","volume":"74","author":"Afonine","year":"2018","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.isci.2026.117166_bib52","unstructured":"The PyMOL Molecular Graphics System, Version 3.0 Schrodinger, LLC."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226025447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226025447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:34:58Z","timestamp":1789047298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226025447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2589004226025447"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.117166","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emergence of neutralizing RBD antibodies following Omicron infection with limited activity against ancestral SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.117166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117166"}}